The AI engine Fit Assessment
BetaThe company provides pharma-focused formulation development, IP strategy, regulatory navigation, and CMC expertise for ophthalmic and injectable drugs, aligning with the pharma tech central requirement.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
At Callan Pharma, we specialize in ophthalmic and parenteral drug formulations,
solving complex challenges in small molecules, polymer excipients, and
nanoparticle systems. With expertise in CMC, IP strategy, and regulatory
approvals, we help biotech and pharma companies accelerate drug development.
What we do:
• Specialized formulations – Ophthalmic, injectable, and subcutaneous drug delivery solutions
• Polymer chemistry & Nanotechnology – Enhancing solubility and bioavailability
• IP & regulatory strategy – Patent protection and global regulatory navigation
• Agile development – Fast, science-driven solutions to keep innovation on track
Why partner with Callan Pharma?
• A science-first approach blending formulation, IP, and regulatory strategy
• A trusted partner for biotech and pharma innovators facing complex formulation challenges